CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Kazam Joshua A Director | Option exercise · Restricted Stock Unit | −47,700 | 47,700 | ||
| 2025-11-17 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | −786 | $1.22 | $959 | 217,721 |
| 2025-10-21 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Sale | −36,744 | $1.26 | $46K | 1,276,796 |
| 2025-06-18 | SATO VICKI L Director | Grant or award · Stock Option (Right to buy) | +144,400 | 144,400 | ||
| 2025-06-18 | MESSEMER DEBORAH M. Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2025-06-18 | Humer Franz B Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2025-06-18 | Barrett Elizabeth A. Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2025-06-18 | Mayo Stephen Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2025-06-18 | WITTE OWEN N. Director | Grant or award · Restricted Stock Unit | +95,400 | 95,400 | ||
| 2025-06-18 | Kazam Joshua A Director | Grant or award · Restricted Stock Unit | +94,500 | 94,500 | ||
| 2025-06-10 | MESSEMER DEBORAH M. Director | Sale 10b5-1 | −36,885 | $1.42 | $52K | 107,431 |
| 2025-04-21 | Yoshiyama Annie SVP, Finance | Sale | −9,601 | $1.41 | $14K | 130,663 |
| 2025-03-14 | Chang David D President and CEO | Sale | −46,668 | $1.96 | $91K | 5,276,569 |
| 2025-03-14 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Sale | −5,488 | $1.98 | $11K | 218,507 |
| 2025-03-01 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Grant or award | +31,755 | 223,995 | ||
| 2025-03-01 | Beneski Benjamin Machinas SVP, Chief Technical Officer | Grant or award · Stock Option (Right to buy) | +112,339 | 112,339 | ||
| 2025-02-18 | MESSEMER DEBORAH M. Director | Sale 10b5-1 | −13,313 | $2.43 | $32K | 144,316 |
| 2025-02-03 | Douglas Earl Martin SVP, General Counsel | Sale | −6,404 | $1.71 | $11K | 587,848 |
| 2025-02-03 | Parker Geoffrey M. CHIEF FINANCIAL OFFICER | Sale | −4,361 | $1.73 | $8K | 1,301,540 |
| 2025-02-03 | MOORE TIMOTHY L. Chief Technical Officer | Sale | −14,746 | $1.71 | $25K | 250,713 |
Page 3 of 18 · 348 trades